Earnings call Caplin Point reported 11% YoY revenue growth and 21.6% YoY PAT growth in H1 FY26, with EBITDA margin expanding to 18.2%. The company remains focused on US and Latin American expansion, ...
Caplin Point Chairman CC Paarthipan said, “The US market remains a key growth engine for the Company, and this acquisition ...
* Seeks shareholders' nod for reappointment of Sridhar Ganesan as the managing director of the company Source text for Eikon: Further company coverage: ...
TipRanks on MSN
Caplin Point buys $473 million portfolio of US-approved injectable and ophthalmic ANDAs
Caplin Point Laboratories Limited ( ($IN:CAPLIPOINT) ) has shared an update. Caplin Point Laboratories, through its subsidiaries Caplin Steriles ...
* DEC QUARTER CONSOL REVENUE FROM OPERATIONS 1.42 BILLION RUPEES VERSUS 1.03 BILLION RUPEES YEAR AGO Source text: bit.ly/2E96FFa Further company coverage: The European Commission proposed ...
When C.C. Paarthipan, a first-gen pharma entrepreneur, listed his tiny Chennai company, Caplin Point Labs--with revenues of less than $1 million--it was oversubscribed 117 times. He raised about ...
Earnings call Caplin Point Laboratories posted a 16.7% YoY revenue growth in Q3 FY25, driven by 23% growth in the U.S. business and 14% growth in Latin America. PAT margin reached 26.1%, exceeding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback